Rx (Prescription Medicine)
USD $ 106.00
Pacliget 30mg 注射液是一种靶向疗法，用于治疗某些类型的癌症。其活性成分为帕克西太太（Paclitaxel），一种强效化疗药物，可通过破坏癌细胞内微管的正常功能发挥作用。微管对于细胞分裂至关重要，而帕克西太太通过干扰其组装和解聚，有效阻止癌细胞的增殖。这种作用机制使其成为对抗多种恶性肿瘤的重要工具。
Pacliget 30mg 注射液适用于晚期卵巢癌、乳腺癌和非小细胞肺癌的治疗。剂量和给药方案由主治医生根据具体的癌症类型、分期、患者的整体健康状况以及对治疗的反应来确定。通常采用静脉给药。
与 Pacliget 30mg 注射液相关的常见不良反应可能包括骨髓抑制（导致血细胞计数下降）、脱发、神经损伤（神经病变）、恶心、呕吐、腹泻以及过敏反应。治疗期间，患者应由其医疗提供者密切监测。Pacliget 30mg 注射液应储存在室温、避光的环境中，且不可冷冻。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength | |
| Brand Name |
其他品牌的 Paclitaxel 30 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
